Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 9:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2617–2640 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: COVID-19
Interventions: Baricitinib, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 1,525 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 25
States / cities: Gilbert, Arizona • Phoenix, Arizona • Newport Beach, California + 20 more

Conditions: Myasthenia Gravis, Generalized
Interventions: mycophenolate mofetil (CellCept), placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 10
States / cities: Sun City, Arizona • Sacramento, California • Miami, Florida + 7 more

Conditions: Physical Activity
Interventions: middle school physical activity intervention for girls; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 10 Years to 14 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Diabetes Mellitus, Type 2
Interventions: PF-04603629, Placebo; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 4
States / cities: Phoenix, Arizona • Miami, Florida • Wichita, Kansas + 1 more

Conditions: Depression, Depressive Disorder, Clinical Depression, Major Depressive Disorder
Interventions: FTP-based therapeutic mobile-app; Other
Lead sponsor: Hedonia Ltd; Industry
Eligibility: 20 Years to 50 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Burnout, Clinical Documentation Efficiency
Interventions: DAX CoPilot Group; Behavioral
Lead sponsor: Samaritan Health Services; Other
Eligibility: Not listed
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Corvallis, Oregon

Conditions: Colon Cancer, Rectal Cancer
Interventions: Moderate-Intensity Aerobic Exercise, Wait-List Control; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Pruritus
Interventions: Dupilumab, Placebo, Fexofenadine (loratadine if not available); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 19
States / cities: Bakersfield, California • La Jolla, California • Washington D.C., District of Columbia + 16 more

Conditions: Prostate Cancer
Interventions: Technology based cognitive behavioral stress management, Technology based health promotion group-based attention matched control condition; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 50 Years and older · Male only
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Herpes Simplex
Interventions: Neem Based External Application Cream; Other
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 18 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Whittier, California

Conditions: Ovarian Failure, Infertility, Female
Interventions: intra-ovarian platelet rich plasma injection; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 38 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Basking Ridge, New Jersey

Conditions: Keratoconus
Interventions: Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment; Combination Product
Lead sponsor: Epion Therapeutics; Industry
Eligibility: 8 Years to 45 Years
Enrollment: 398 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 12
States / cities: Scottsdale, Arizona • Tucson, Arizona • Murrieta, California + 9 more

Conditions: Obesity and Overweight, Breastfeeding, Exclusive
Interventions: Chia seeds; Dietary Supplement
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 45 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Oklahoma City, Oklahoma

Conditions: Type 2 Diabetes, Overweight and Obese Adults
Interventions: Low-fat, vegan diet; Behavioral
Lead sponsor: Physicians Committee for Responsible Medicine; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Pelvic Organ Prolapse, Urinary Incontinence
Interventions: Patient reminder system; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hyperhidrosis
Interventions: WL8713, 6 mg, WL8713, 12 mg, WL8713, 18 mg, WL8713, 24 mg, Placebo; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: Opioid Use
Interventions: Educational materials; Other
Lead sponsor: Brendan M. Patterson; Other
Eligibility: 21 Years to 99 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Respiratory Syncytial Virus Infections
Interventions: Investigational RSV vaccine 1, Investigational RSV vaccine 2, Investigational RSV vaccine 3, Investigational RSV vaccine 4, Investigational RSV vaccine 5, Investigational RSV vaccine 6, Placebo; Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 213 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 5
States / cities: Rolling Hills Estates, California • Atlanta, Georgia • Lenexa, Kansas + 2 more

Conditions: Respiratory Failure, Volume Overload, Hypernatremia
Interventions: Supplemental metolazone diuresis, Placebo Comparator: Control-- furosemide (lasix) only; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: HIV
Interventions: SystemCHANGE-HIV; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 21 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Injuries
Interventions: A pre-dive checklist; Other
Lead sponsor: Divers Alert Network; Network
Eligibility: 18 Years and older
Enrollment: 1,116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Female Orgasmic Disorder
Interventions: Placebo, Low dose TBS-2, Medium dose TBS-2, High dose TBS-2; Drug
Lead sponsor: Acerus Pharmaceuticals Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 43
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chandler, Arizona + 37 more

Conditions: Educational Problems
Interventions: Flipped Classroom Approach; Other
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Multiple Sclerosis
Interventions: Shepherd CAN DO Program; Behavioral
Lead sponsor: Shepherd Center, Atlanta GA; Other
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

A Study of Baricitinib (LY3009104) in Participants With COVID-19

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

Middle School Physical Activity Intervention for Girls

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

A Treatment for Depression Via a Gamified Mobile Phone Application Based on a New Cognitive Model

Evaluating the Impact of Ambient AI on Documentation Efficiency and Clinician Burnout in Primary Care Settings

The Exercise And Colorectal Cancer Treatment Trial

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer

Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis

Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response

Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Impact of Chia Seeds on Human Breast Milk Composition

Plant-Based Online Weight Loss Through Education and Resources Program and Study

Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems

Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis

Opioid Consumption and Disposal After Shoulder Arthroplasty

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis

Study of SystemCHANGE-HIV

Common Recreational Diving Practices: A Randomized Control Trial Using Pre-Dive Checklist

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

The Flipped Classroom Approach in Ophthalmology Residency

Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program